Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BD Secondary Infusion Set

K-Number: K223101 · 2023-05-12

ApplicantCare Fusion
Decision Date2023-05-12
Product CodeFPA
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

BD Secondary Infusion Set is the device name listed in this FDA 510(k) record. The listed applicant is Care Fusion. It received FDA 510(k) clearance on 2023-05-12 under 510(k) number K223101. The device is classified under product code FPA. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BD Secondary Infusion Set?

BD Secondary Infusion Set is a medical device that received FDA 510(k) clearance on 2023-05-12. The listed applicant is Care Fusion. The 510(k) number is K223101.

When did BD Secondary Infusion Set receive FDA 510(k) clearance?

BD Secondary Infusion Set received FDA 510(k) clearance on 2023-05-12, under 510(k) number K223101.

Who is the listed applicant for BD Secondary Infusion Set?

The FDA 510(k) record lists Care Fusion as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BD Secondary Infusion Set?

The FDA product code for BD Secondary Infusion Set is FPA.

Other records listing Care Fusion as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 14 devices →

Related Devices (Code: FPA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.